Tranexamic Acid in Gender Mastectomy
- Conditions
- Surgery
- Interventions
- Drug: Tranexamic Acid IrrigationOther: Saline Irrigation
- Registration Number
- NCT04372940
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
The goal of this study is to examine the use of tranexamic acid (TXA) in gender mastectomy surgery, specifically looking at volume loss (blood and transudate) postoperatively.
- Detailed Description
Anecdotal data from plastic surgeons around the country suggests that tranexamic acid has decreased patient's drain outputs, swelling, and bruising. Based on these anecdotal reports, many University of Wisconsin (UW) surgeons in Plastic and Reconstructive Surgery became interested in its use. It has a very safe profile and is inexpensive; therefore, many UW plastic surgeons have started using it topically prior to closure in many of procedures. Surgeons notice decreased drain output and bruising; and therefore decided to formally study the effects of tranexamic acid to determine whether there was a statistical difference in outcomes with the use of the drug.
For this sub-study, topical TXA will be applied to the surface of surgical sites and the primary outcome will be days to drain removal postoperatively. Secondary outcomes that would be assessed is total drain fluid output in milliliters, hematoma and seroma rates, and need for transfusion for hemoglobin \< 7.0 postoperatively.
The hypothesis is that the use of TXA will result in earlier removal of drains by decreasing total drain fluid output and decreased need for transfusions, thus minimizing the associated complications/risks with drains and transfusions. The overall study is in two-parts, 1) a prospective study with retrospective controls via chart review and 2) a prospective controlled trial in bilateral procedures where participants serve as their own control with one side having tranexamic acid irrigation and the other side having saline irrigation.
This record documents a prospective controlled trial of the use of TXA in gender mastectomy, specifically.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- Undergoing gender mastectomy
- English speaking
- History of thrombotic event (ie deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction)
- genetic disorder that increases risk of thrombosis
- use of estrogens at time of surgery
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intervention Side: TXA Irrigation Tranexamic Acid Irrigation 2.5% tranexamic acid will be applied directly to the wound via bulb irrigation and left in place for 5 minutes in the wound bed Control Side: Saline Irrigation Saline Irrigation Contralateral side will serve as a control
- Primary Outcome Measures
Name Time Method Days until drain removal up to 30 days post-op
- Secondary Outcome Measures
Name Time Method Drain fluid output in mL/day up to 30 days post-op Number of hematomas requiring aspiration or return to the operating room in the 30 days following surgery up to 30 days post-op Amount of fluid evacuated (mL) - hematomas up to 30 days post-op Amount of fluid evacuated (mL) if hematomas require aspiration or return to the operating room in the 30 days following surgery
Total drain output in mL for total time drain is in place up to 30 days post-op Number of Participants requiring transfusion for hemoglobin (Hgb) < 7.0 during postoperative admission up to 30 days post-op Number of seromas requiring aspiration or return to the operating room in the 30 days following surgery up to 30 days post-op Amount of fluid evacuated (mL) - seromas up to 30 days post-op Amount of fluid evacuated (mL) if seromas require aspiration or return to the operating room in the 30 days following surgery
Number of units of blood transfused to maintain Hgb >7.0 in the postoperative admission up to 30 days post-op
Trial Locations
- Locations (1)
University of Wisconsin Hospital and Clinics
🇺🇸Madison, Wisconsin, United States